(Q52941261)

9 May 2018

title

Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study. (English)

1 reference

9 May 2018

author name string

Jennifer A Crossley

1

1 reference

9 May 2018

David A Aitken

2

1 reference

9 May 2018

Alan D Cameron

3

1 reference

9 May 2018

Elizabeth McBride

4

1 reference

9 May 2018

J Michael Connor

5

1 reference

9 May 2018

publication date

1 June 2002

1 reference

9 May 2018

BJOG: an International Journal of Obstetrics and Gynaecology

published in

1 reference

9 May 2018

volume

109

1 reference

9 May 2018

issue

6

1 reference

9 May 2018

page(s)

667-676

1 reference

9 May 2018

Ultrasound screening for fetal abnormalities in the first trimester

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

Appropriate biochemical parameters in first-trimester screening for Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

Repeatability of measurement of fetal nuchal translucency thickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

Nuchal translucency audit: a novel image-scoring method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

Free beta-hCG as first-trimester marker for fetal trisomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

Screening for Down syndrome during first trimester: a prospective study using free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

First-trimester screening for Down syndrome using nuchal translucency measurement with free beta-hCG and PAPP-A between 10 and 13 weeks of pregnancy--the combined test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

Deriving risks of Down's syndrome from nuchal translucency measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2002.01394.X

10.1111/J.1471-0528.2002.01394.X

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018